LINCOLN NATIONAL CORP - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 58 filers reported holding ATOSSA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
LINCOLN NATIONAL CORP ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$7,495
+37.1%
10,3400.0%0.00%
Q4 2022$5,465
-39.3%
10,3400.0%0.00%
Q3 2022$9,000
-18.2%
10,3400.0%0.00%
Q2 2022$11,000
-15.4%
10,3400.0%0.00%
Q1 2022$13,000
-23.5%
10,3400.0%0.00%
Q4 2021$17,000
-50.0%
10,3400.0%0.00%
-100.0%
Q3 2021$34,000
-47.7%
10,3400.0%0.00%0.0%
Q2 2021$65,000
+132.1%
10,340
-20.5%
0.00%0.0%
Q1 2021$28,00013,0000.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 347,392$2560.02%
XTX Topco Ltd 167,427$123,3100.02%
Laurion Capital Management LP 2,225,800$1,639,3020.01%
Virtu Financial LLC 80,728$590.01%
Renaissance Technologies 1,242,370$9150.00%
LVM CAPITAL MANAGEMENT LTD/MI 21,000$150.00%
EDMOND DE ROTHSCHILD HOLDING S.A. 50,000$36,8250.00%
Connor, Clark & Lunn Investment Management Ltd. 133,591$98,3900.00%
Caption Management, LLC 75,000$55,2380.00%
J. L. Bainbridge & Co., Inc. 11,121$8,1910.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders